Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests

Cologuard growth accelerates to $48.4 million in revenue during first quarter; volume grows 150 percent year over year to 100,000 completed tests

CMS includes Cologuard in updated Medicare Advantage Star Ratings

Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase

CMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings

Exact Sciences to report $99 million in revenues, 150 percent growth for 2016

Cologuard Earns Positive Review from Blue Cross Blue Shield Association